Dedeoglu A - Search Results

1

Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.

Korkmaz OT, Ay H, Aytan N, Carreras I, Kowall NW, Dedeoglu A, Tuncel N. Korkmaz OT, et al. Among authors: dedeoglu a. J Mol Neurosci. 2019 Jul;68(3):389-396. doi: 10.1007/s12031-018-1226-8. Epub 2018 Nov 29. J Mol Neurosci. 2019. PMID: 30498985

2

Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid.

Andreassen OA, Ferrante RJ, Klivenyi P, Klein AM, Dedeoglu A, Albers DS, Kowall NW, Beal MF. Andreassen OA, et al. Among authors: dedeoglu a. Exp Neurol. 2001 Apr;168(2):356-63. doi: 10.1006/exnr.2001.7627. Exp Neurol. 2001. PMID: 11259123

3

Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis.

Ferrante RJ, Klein AM, Dedeoglu A, Beal MF. Ferrante RJ, et al. Among authors: dedeoglu a. J Mol Neurosci. 2001 Aug;17(1):89-96. doi: 10.1385/jmn:17:1:89. J Mol Neurosci. 2001. PMID: 11665866

4

Cytochrome C and caspase-9 expression in Huntington's disease.

Kiechle T, Dedeoglu A, Kubilus J, Kowall NW, Beal MF, Friedlander RM, Hersch SM, Ferrante RJ. Kiechle T, et al. Among authors: dedeoglu a. Neuromolecular Med. 2002;1(3):183-95. doi: 10.1385/NMM:1:3:183. Neuromolecular Med. 2002. PMID: 12095160

5

Therapeutic effects of cystamine in a murine model of Huntington's disease.

Dedeoglu A, Kubilus JK, Jeitner TM, Matson SA, Bogdanov M, Kowall NW, Matson WR, Cooper AJ, Ratan RR, Beal MF, Hersch SM, Ferrante RJ. Dedeoglu A, et al. J Neurosci. 2002 Oct 15;22(20):8942-50. doi: 10.1523/JNEUROSCI.22-20-08942.2002. J Neurosci. 2002. PMID: 12388601 Free PMC article.

6

Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.

Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG. Dedeoglu A, et al. Brain Res. 2004 Jun 25;1012(1-2):60-5. doi: 10.1016/j.brainres.2004.02.079. Brain Res. 2004. PMID: 15158161

7

Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.

Dedeoglu A, Cormier K, Payton S, Tseitlin KA, Kremsky JN, Lai L, Li X, Moir RD, Tanzi RE, Bush AI, Kowall NW, Rogers JT, Huang X. Dedeoglu A, et al. Exp Gerontol. 2004 Nov-Dec;39(11-12):1641-9. doi: 10.1016/j.exger.2004.08.016. Exp Gerontol. 2004. PMID: 15582280

8

Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice.

Stack EC, Dedeoglu A, Smith KM, Cormier K, Kubilus JK, Bogdanov M, Matson WR, Yang L, Jenkins BG, Luthi-Carter R, Kowall NW, Hersch SM, Beal MF, Ferrante RJ. Stack EC, et al. Among authors: dedeoglu a. J Neurosci. 2007 Nov 21;27(47):12908-15. doi: 10.1523/JNEUROSCI.4318-07.2007. J Neurosci. 2007. PMID: 18032664 Free PMC article.

9

Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.

McKee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S, LaFerla FM, Jenkins BG, Kowall NW, Dedeoglu A. McKee AC, et al. Among authors: dedeoglu a. Brain Res. 2008 May 1;1207:225-36. doi: 10.1016/j.brainres.2008.01.095. Epub 2008 Feb 16. Brain Res. 2008. PMID: 18374906 Free PMC article.

10

Extralarge XL(alpha)s (XXL(alpha)s), a variant of stimulatory G protein alpha-subunit (Gs(alpha)), is a distinct, membrane-anchored GNAS product that can mimic Gs(alpha).

Aydin C, Aytan N, Mahon MJ, Tawfeek HA, Kowall NW, Dedeoglu A, Bastepe M. Aydin C, et al. Among authors: dedeoglu a. Endocrinology. 2009 Aug;150(8):3567-75. doi: 10.1210/en.2009-0318. Epub 2009 May 7. Endocrinology. 2009. PMID: 19423757 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page